Research Projects on Health and Care

  • Measuring the distribution of benefits of research and innovation

    Economic analyses offer a compelling case for the benefits that research and innovation (R&I) can deliver, but R&I also offers numerous benefits that are either not easily monetised or not well understood. These include benefits to culture, public engagement, social cohesion and the environment.

    13 Dec 2018

  • How to enable NHS staff to contribute to healthcare research

    The Healthcare Improvement Studies Institute sought evidence of why and how NHS staff contribute to healthcare research, as well as their associated engagement challenges and potential enabling mechanisms.

    12 Dec 2018

  • Requiring repayment of incentives encourages greater wellness

    Wellness incentives are more successful when they provide a benefit up front and require repayment if recipients do not maintain a required level of activity, according to a longitudinal study of nearly 500,000 programme participants.

    27 Nov 2018

  • Evaluation suggests next steps for Dance4Life

    Dance4life, an international youth initiative to raise awareness and promote prevention of HIV/AIDS, developed and piloted a new programme and implementation model. An evaluation of the pilot found many successes but also areas where improvements could be made.

    21 Nov 2018

  • Measuring employee engagement in the NHS

    Analysis of the NHS Healthy Workforce Survey and VitalityHealth’s Britain’s Healthiest Workplace survey found that staff engagement in the NHS is similar to other large UK employers with a similar demographic composition, and that demographic factors such as gender and age are associated with different levels of engagement.

    11 Oct 2018

  • Additional metrics can help Tommy's measure their impact

    Because of its growth, the UK charity Tommy’s is developing a new strategy for their spending on efforts to reduce stillbirth, preterm birth, and miscarriages. Researchers examined the metrics Tommy's currently uses and suggested additional metrics to measure the impact of the charity's work.

    18 Sep 2018

  • Evaluating the Q Improvement Lab

    RAND Europe and the University of Cambridge tested whether the Q Improvement Lab approach could become an effective, valuable way of developing ideas or interventions to support positive change at multiple levels of the health and care system.

    14 Sep 2018

  • Eastern AHSN Transformation Support Unit Shows Positive Impact

    Stakeholders and 'customers' say the Eastern Academic Health Science Network's TSU—which helps implement innovative solutions to challenges faced by health and care providers—has supported them with their pilots and network building. An evaluation provides recommendations for further improvements.

    03 Aug 2018

  • Research identifies promising practices in health and wellbeing at work

    Many health and wellbeing interventions are available to UK employers. Researchers graded them against Nesta standards and developed case studies of the most promising practices that support policy and organisational decision making.

    25 Jul 2018

  • Investigating Social Impact Bonds for Health and Social Care

    Health and social care services in five SIB-funded projects were more flexibly provided than in similar non-SIB projects, but it is unclear whether this resulted in better client outcomes. Attribution of outcomes to the SIB-financed intervention should be prioritised in the future.

    20 Jul 2018

  • Updating an Evaluation of Grant Peer Review in the Health Sciences

    The Canadian Institutes of Health Research asked RAND Europe to update the 2009 study on grant peer review to provide a more widely applicable source of evidence around the strengths and weaknesses of peer review for grant funding assessment.

    15 Jun 2018

  • Using historical foresight to tackle antimicrobial resistance (AMR)

    Researchers are examining complex and enduring policy issues that have implications for public health (climate change and tobacco control) to gain a new perspective on how to tackle AMR. The team will look at how historical analysis can be used in future approaches to scenario planning and policymaking, with a particular focus on AMR policy.

    16 Apr 2018

  • Pre-Evaluation of the Communities of Practice (CoPs) Programme

    Researchers conducted a scoping exercise to help plan and prepare for a more systematic and complete evaluation of the Health Innovation Network's Communities of Practice, while also providing immediate evidence to help CoPs improve their effectiveness.

    20 Mar 2018

  • Exploring the implementation of new cardiovascular risk assessment tools

    As part of the pan-EU project EPIC-CVD, which aims to provide clinicians and policymakers with a range of evidence-based policy options for cost-effective, individualised risk assessment for cardiovascular disease, researchers explored options for the implementation of new cardiovascular risk assessment tools across Europe.

    19 Mar 2018

  • Evaluating the Optimal Lengths of Prescription Plans

    A review of clinical and economic evidence, followed by economic modelling, suggests that the NHS should rethink its policies and guidance promoting 28-day vs three-month prescription lengths. Three-month prescriptions were associated with lower administrative costs and improved medication adherence.

    14 Mar 2018

  • Evaluating the Impact of EU R&D into PRNDs

    EU-funded research and development into poverty-related and neglected diseases has had a significant impact on strengthening research capacity in low- and middle-income countries, but its effects on encouraging universal health coverage is less clear.

    21 Feb 2018

  • Calculating the Economic Returns of Musculoskeletal Research

    A team of researchers from RAND Europe, King’s College London and HERG estimated the health and economic benefits of UK investment in medical research into musculoskeletal disease (MSD). Their best estimate of the internal rate of return from MSD-related research was 7%, which is similar to the 9% for cardiovascular disease and 10% for cancer research.

    26 Jan 2018